Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?

doi:10.2174/1389450111314020005

Back to search

Article

Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?

Current drug targets - 1 Feb 2013

Kostikas Konstantinos, Bakakos Petros, Papiris Spyros, Stolz Daiana, Celli Bartolome R

Abstract excerpt

Chronic obstructive pulmonary disease (COPD) is a complex, multicomponent disease at the clinical, cellular, and molecular levels. Over the past few years there has been a growing interest in the field of biomarkers in COPD and a large number of studies have evaluated potential candidate molecule...

Topics

Biomarkers
Humans
Inflammation
Phenotype
Pulmonary Disease, Chronic Obstructive
Severity of Illness Index
Treatment Outcome

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.